nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1A—Parkinson's disease	0.832	1	CbGaD
Frovatriptan—HTR1B—telencephalic ventricle—Parkinson's disease	0.0072	0.131	CbGeAlD
Frovatriptan—HTR1D—telencephalic ventricle—Parkinson's disease	0.00697	0.127	CbGeAlD
Frovatriptan—HTR1A—telencephalic ventricle—Parkinson's disease	0.00581	0.106	CbGeAlD
Frovatriptan—HTR1A—hindbrain—Parkinson's disease	0.00274	0.05	CbGeAlD
Frovatriptan—HTR1B—brainstem—Parkinson's disease	0.00195	0.0355	CbGeAlD
Frovatriptan—HTR1D—brainstem—Parkinson's disease	0.00189	0.0344	CbGeAlD
Frovatriptan—HTR1B—forebrain—Parkinson's disease	0.00188	0.0343	CbGeAlD
Frovatriptan—HTR1D—forebrain—Parkinson's disease	0.00182	0.0332	CbGeAlD
Frovatriptan—HTR1B—cardiovascular system—Parkinson's disease	0.00159	0.029	CbGeAlD
Frovatriptan—HTR1A—brainstem—Parkinson's disease	0.00157	0.0286	CbGeAlD
Frovatriptan—HTR1D—cardiovascular system—Parkinson's disease	0.00154	0.028	CbGeAlD
Frovatriptan—HTR1A—forebrain—Parkinson's disease	0.00152	0.0276	CbGeAlD
Frovatriptan—HTR1A—cardiovascular system—Parkinson's disease	0.00128	0.0234	CbGeAlD
Frovatriptan—HTR1B—midbrain—Parkinson's disease	0.00124	0.0226	CbGeAlD
Frovatriptan—HTR1B—spinal cord—Parkinson's disease	0.00121	0.0221	CbGeAlD
Frovatriptan—HTR1D—midbrain—Parkinson's disease	0.0012	0.0219	CbGeAlD
Frovatriptan—HTR1B—head—Parkinson's disease	0.00108	0.0196	CbGeAlD
Frovatriptan—HTR1D—head—Parkinson's disease	0.00104	0.019	CbGeAlD
Frovatriptan—HTR1B—nervous system—Parkinson's disease	0.00102	0.0186	CbGeAlD
Frovatriptan—HTR1A—midbrain—Parkinson's disease	0.001	0.0183	CbGeAlD
Frovatriptan—HTR1D—nervous system—Parkinson's disease	0.000989	0.018	CbGeAlD
Frovatriptan—HTR1B—central nervous system—Parkinson's disease	0.000983	0.0179	CbGeAlD
Frovatriptan—HTR1A—spinal cord—Parkinson's disease	0.000978	0.0178	CbGeAlD
Frovatriptan—HTR1D—central nervous system—Parkinson's disease	0.000952	0.0173	CbGeAlD
Frovatriptan—HTR1A—head—Parkinson's disease	0.000869	0.0158	CbGeAlD
Frovatriptan—HTR1A—nervous system—Parkinson's disease	0.000824	0.015	CbGeAlD
Frovatriptan—HTR1A—central nervous system—Parkinson's disease	0.000793	0.0145	CbGeAlD
Frovatriptan—HTR1B—brain—Parkinson's disease	0.000781	0.0142	CbGeAlD
Frovatriptan—HTR1A—cerebellum—Parkinson's disease	0.000775	0.0141	CbGeAlD
Frovatriptan—HTR1D—brain—Parkinson's disease	0.000756	0.0138	CbGeAlD
Frovatriptan—HTR1A—brain—Parkinson's disease	0.00063	0.0115	CbGeAlD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000138	0.00122	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000138	0.00122	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—DRD2—Parkinson's disease	0.000138	0.00122	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR7—Parkinson's disease	0.000138	0.00122	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PDYN—Parkinson's disease	0.000137	0.00121	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PENK—Parkinson's disease	0.000136	0.00121	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PDYN—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PENK—Parkinson's disease	0.000133	0.00118	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GRK5—Parkinson's disease	0.000132	0.00116	CbGpPWpGaD
Frovatriptan—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000131	0.00116	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000129	0.00115	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—GRM5—Parkinson's disease	0.000127	0.00113	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000127	0.00112	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—GRM5—Parkinson's disease	0.000125	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DGKQ—Parkinson's disease	0.000125	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GPR37—Parkinson's disease	0.000125	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PDYN—Parkinson's disease	0.000125	0.0011	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TAC1—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GPR37—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DGKQ—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PDYN—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD1—Parkinson's disease	0.00012	0.00106	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GRK5—Parkinson's disease	0.000119	0.00106	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GRM4—Parkinson's disease	0.000118	0.00104	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD3—Parkinson's disease	0.000116	0.00103	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—GRM5—Parkinson's disease	0.000116	0.00103	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000115	0.00102	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000114	0.00101	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—GRM5—Parkinson's disease	0.000113	0.001	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000113	0.000998	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—EDN1—Parkinson's disease	0.000113	0.000998	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—VPS35—Parkinson's disease	0.000112	0.000995	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PENK—Parkinson's disease	0.000112	0.00099	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000112	0.00099	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00011	0.000978	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—EDN1—Parkinson's disease	0.00011	0.000977	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00011	0.000977	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000109	0.000963	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000108	0.00096	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GRM4—Parkinson's disease	0.000107	0.000949	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000106	0.00094	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR7—Parkinson's disease	0.000105	0.00093	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—DRD2—Parkinson's disease	0.000105	0.00093	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PDYN—Parkinson's disease	0.000102	0.000906	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PENK—Parkinson's disease	0.000102	0.000899	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000101	0.000893	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	9.99e-05	0.000885	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—RIT2—Parkinson's disease	9.98e-05	0.000884	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	9.97e-05	0.000883	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.95e-05	0.000881	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2A—Parkinson's disease	9.86e-05	0.000873	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADORA2A—Parkinson's disease	9.84e-05	0.000872	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—RIT2—Parkinson's disease	9.77e-05	0.000865	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.66e-05	0.000855	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2A—Parkinson's disease	9.66e-05	0.000855	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADORA2A—Parkinson's disease	9.64e-05	0.000854	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—GRM5—Parkinson's disease	9.51e-05	0.000842	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GRK5—Parkinson's disease	9.46e-05	0.000838	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR1A—Parkinson's disease	9.41e-05	0.000833	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DGKQ—Parkinson's disease	9.31e-05	0.000824	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GPR37—Parkinson's disease	9.31e-05	0.000824	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PDYN—Parkinson's disease	9.29e-05	0.000823	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TAC1—Parkinson's disease	9.26e-05	0.00082	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GRK5—Parkinson's disease	9.26e-05	0.00082	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	9.22e-05	0.000817	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR1A—Parkinson's disease	9.21e-05	0.000816	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD1—Parkinson's disease	9.08e-05	0.000804	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TAC1—Parkinson's disease	9.07e-05	0.000803	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD1—Parkinson's disease	8.9e-05	0.000788	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD3—Parkinson's disease	8.8e-05	0.000779	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—GRM5—Parkinson's disease	8.64e-05	0.000765	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD3—Parkinson's disease	8.61e-05	0.000763	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR1A—Parkinson's disease	8.54e-05	0.000756	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PPP1R1B—Parkinson's disease	8.52e-05	0.000754	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GRM4—Parkinson's disease	8.49e-05	0.000751	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TAC1—Parkinson's disease	8.41e-05	0.000745	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—EDN1—Parkinson's disease	8.41e-05	0.000745	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR1A—Parkinson's disease	8.36e-05	0.000741	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—COMT—Parkinson's disease	8.36e-05	0.00074	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	8.36e-05	0.00074	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	8.36e-05	0.00074	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	8.32e-05	0.000737	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GRM4—Parkinson's disease	8.31e-05	0.000736	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	8.3e-05	0.000735	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD1—Parkinson's disease	8.25e-05	0.000731	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	8.24e-05	0.00073	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TAC1—Parkinson's disease	8.24e-05	0.000729	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.22e-05	0.000728	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	8.2e-05	0.000727	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.09e-05	0.000716	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD1—Parkinson's disease	8.08e-05	0.000715	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.04e-05	0.000712	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAG—Parkinson's disease	8.04e-05	0.000712	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PENK—Parkinson's disease	8.04e-05	0.000712	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD3—Parkinson's disease	7.99e-05	0.000707	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—DRD2—Parkinson's disease	7.96e-05	0.000705	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR7—Parkinson's disease	7.96e-05	0.000705	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PENK—Parkinson's disease	7.88e-05	0.000697	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAG—Parkinson's disease	7.88e-05	0.000697	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD3—Parkinson's disease	7.82e-05	0.000693	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—DRD2—Parkinson's disease	7.79e-05	0.00069	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR7—Parkinson's disease	7.79e-05	0.00069	CbGpPWpGaD
Frovatriptan—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	7.64e-05	0.000677	CbGpPWpGaD
Frovatriptan—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	7.54e-05	0.000668	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—ADRBK1—Parkinson's disease	7.46e-05	0.000661	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—RIT2—Parkinson's disease	7.44e-05	0.000659	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PDYN—Parkinson's disease	7.36e-05	0.000651	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2A—Parkinson's disease	7.36e-05	0.000651	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADORA2A—Parkinson's disease	7.34e-05	0.00065	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—ADRBK1—Parkinson's disease	7.31e-05	0.000647	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	7.25e-05	0.000642	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR7—Parkinson's disease	7.23e-05	0.00064	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—DRD2—Parkinson's disease	7.23e-05	0.00064	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PDYN—Parkinson's disease	7.2e-05	0.000638	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR7—Parkinson's disease	7.08e-05	0.000626	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—DRD2—Parkinson's disease	7.08e-05	0.000626	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GRK5—Parkinson's disease	7.06e-05	0.000625	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GFAP—Parkinson's disease	6.92e-05	0.000612	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TAC1—Parkinson's disease	6.91e-05	0.000612	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—GRM5—Parkinson's disease	6.84e-05	0.000606	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD1—Parkinson's disease	6.78e-05	0.0006	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GFAP—Parkinson's disease	6.77e-05	0.0006	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—GRM5—Parkinson's disease	6.7e-05	0.000593	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD3—Parkinson's disease	6.56e-05	0.000581	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—EDN1—Parkinson's disease	6.37e-05	0.000564	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GRM4—Parkinson's disease	6.33e-05	0.00056	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TAC1—Parkinson's disease	6.27e-05	0.000556	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—EDN1—Parkinson's disease	6.24e-05	0.000552	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD1—Parkinson's disease	6.15e-05	0.000545	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.13e-05	0.000543	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PENK—Parkinson's disease	6e-05	0.000531	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAG—Parkinson's disease	6e-05	0.000531	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGF20—Parkinson's disease	6e-05	0.000531	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD3—Parkinson's disease	5.96e-05	0.000528	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—DRD2—Parkinson's disease	5.94e-05	0.000526	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR7—Parkinson's disease	5.94e-05	0.000526	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGF20—Parkinson's disease	5.87e-05	0.00052	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	5.85e-05	0.000518	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	5.82e-05	0.000515	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	5.78e-05	0.000512	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.76e-05	0.00051	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	5.69e-05	0.000504	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	5.66e-05	0.000502	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	5.57e-05	0.000493	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	5.56e-05	0.000493	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	5.49e-05	0.000486	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	5.46e-05	0.000483	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MCCC1—Parkinson's disease	5.42e-05	0.00048	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ND3—Parkinson's disease	5.42e-05	0.00048	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	5.39e-05	0.000477	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	5.39e-05	0.000477	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INSR—Parkinson's disease	5.37e-05	0.000475	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INSR—Parkinson's disease	5.26e-05	0.000465	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	5.16e-05	0.000457	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	5.1e-05	0.000452	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—OMD—Parkinson's disease	5.1e-05	0.000451	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TALDO1—Parkinson's disease	5.1e-05	0.000451	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—FGB—Parkinson's disease	5.07e-05	0.000449	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	5.06e-05	0.000448	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	5.05e-05	0.000447	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	4.97e-05	0.00044	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—FGB—Parkinson's disease	4.97e-05	0.00044	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	4.96e-05	0.000439	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	4.94e-05	0.000438	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	4.87e-05	0.000432	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	4.87e-05	0.000431	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	4.83e-05	0.000428	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	4.77e-05	0.000423	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	4.75e-05	0.000421	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	4.72e-05	0.000418	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	4.62e-05	0.000409	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GCH1—Parkinson's disease	4.61e-05	0.000408	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	4.47e-05	0.000396	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	4.41e-05	0.00039	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	4.34e-05	0.000384	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	4.32e-05	0.000382	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	4.31e-05	0.000382	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	4.27e-05	0.000378	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	4.27e-05	0.000378	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	4.18e-05	0.00037	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	4.18e-05	0.00037	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.16e-05	0.000368	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.16e-05	0.000368	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GBA—Parkinson's disease	4.11e-05	0.000364	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DBH—Parkinson's disease	4.11e-05	0.000364	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—FBP1—Parkinson's disease	4.11e-05	0.000364	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INSR—Parkinson's disease	4e-05	0.000354	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—FGB—Parkinson's disease	3.78e-05	0.000335	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	3.77e-05	0.000334	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	3.71e-05	0.000328	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	3.64e-05	0.000322	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	3.58e-05	0.000317	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	3.52e-05	0.000312	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	3.5e-05	0.00031	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	3.46e-05	0.000306	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	3.42e-05	0.000303	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	3.39e-05	0.0003	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	3.35e-05	0.000296	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	3.29e-05	0.000291	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	3.18e-05	0.000282	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	3.18e-05	0.000282	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NGF—Parkinson's disease	3.14e-05	0.000278	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NGF—Parkinson's disease	3.07e-05	0.000272	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—DDC—Parkinson's disease	3.02e-05	0.000267	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	2.99e-05	0.000265	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	2.93e-05	0.000259	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.85e-05	0.000252	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.81e-05	0.000249	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—APOE—Parkinson's disease	2.78e-05	0.000246	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—APOE—Parkinson's disease	2.72e-05	0.000241	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	2.67e-05	0.000236	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	2.58e-05	0.000228	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.56e-05	0.000227	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	2.55e-05	0.000226	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MAOB—Parkinson's disease	2.54e-05	0.000225	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.42e-05	0.000214	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—INS—Parkinson's disease	2.37e-05	0.00021	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NGF—Parkinson's disease	2.34e-05	0.000207	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—INS—Parkinson's disease	2.32e-05	0.000206	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	2.23e-05	0.000197	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—APOE—Parkinson's disease	2.07e-05	0.000184	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.89e-05	0.000167	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.85e-05	0.000164	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—INS—Parkinson's disease	1.77e-05	0.000157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	1.77e-05	0.000157	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	1.76e-05	0.000156	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	1.73e-05	0.000153	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.73e-05	0.000153	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	1.72e-05	0.000152	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.71e-05	0.000151	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—TH—Parkinson's disease	1.68e-05	0.000149	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	1.62e-05	0.000144	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.61e-05	0.000143	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	1.59e-05	0.000141	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—COMT—Parkinson's disease	1.43e-05	0.000127	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.42e-05	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.42e-05	0.000126	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.4e-05	0.000124	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.35e-05	0.000119	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	1.32e-05	0.000117	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	1.31e-05	0.000116	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.31e-05	0.000116	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.25e-05	0.000111	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	1.21e-05	0.000107	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.16e-05	0.000102	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—APOE—Parkinson's disease	1.08e-05	9.53e-05	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.04e-05	9.19e-05	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.02e-05	9e-05	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—INS—Parkinson's disease	9.19e-06	8.14e-05	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—IL6—Parkinson's disease	7.74e-06	6.85e-05	CbGpPWpGaD
